Literature DB >> 10079189

Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.

N Hazeki1, K Nakamura, J Goto, I Kanazawa.   

Abstract

Huntington's disease (HD) is caused by an expansion of the CAG repeat in the HD gene. The repeat is translated to the polyglutamine tract as huntingtin, the product of HD gene. Several studies showed that the expansion of polyglutamine tract leads to formation of cytoplasminc and/or intranuclear aggregates in vivo or in vitro. To understand the molecular mechanism of the aggregate formation, we studied the transient expression of HD exon 1-GFP fusion proteins in COS-7 cells. The fusion protein carrying 77 glutamine repeats aggregated in a time-dependent manner, while the fusion protein carrying 25 glutamine tract remained to be distributed diffusely in the cytoplasm even 72 hours after transfection. Initially, fluorescent signals were diffusely distributed in the COS-7 cells that were transfected with the construct containing the 77 CAG repeats. Approximately 40 hours later after the transfection, large aggregates grew very rapidly in those cells and the diffuse cytoplasmic fluorescence faded out. This process was completed within 40 minutes from the appearance of small aggregates in the perinuclear regions. The addition of cycloheximide reduced the frequencies of aggregate formation. A possibility was discussed that the aggregate formation was via nucleation. The focal concentration of mutated proteins in neurons may trigger the aggregate formation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079189     DOI: 10.1006/bbrc.1999.0337

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!

Authors:  Mohammad Mehdi Banoei; Massoud Houshmand; Mehdi Shafa Shariat Panahi; Parvin Shariati; Maryam Rostami; Masoumeh Dehghan Manshadi; Tayebeh Majidizadeh
Journal:  Cell Mol Neurobiol       Date:  2007-10-20       Impact factor: 5.046

2.  Abnormalities in the tricarboxylic Acid cycle in Huntington disease and in a Huntington disease mouse model.

Authors:  Nima N Naseri; Hui Xu; Joseph Bonica; Jean Paul G Vonsattel; Etty P Cortes; Larry C Park; Jamshid Arjomand; Gary E Gibson
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

3.  Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine.

Authors:  S Iuchi; G Hoffner; P Verbeke; P Djian; H Green
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

4.  Investigation of tRNA(Leu/Lys) and ATPase 6 genes mutations in Huntington's disease.

Authors:  Sadaf Kasraie; Massoud Houshmand; Mohammad Mehdi Banoei; Solmaz Etemad Ahari; Mehdi Shafa Shariat Panahi; Parvin Shariati; Mohammad Bahar; Mostafa Moin
Journal:  Cell Mol Neurobiol       Date:  2008-04-02       Impact factor: 5.046

5.  Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.

Authors:  Erik Kvam; Brent L Nannenga; Min S Wang; Zongjian Jia; Michael R Sierks; Anne Messer
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

6.  Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum.

Authors:  Andrea N Ortiz; Benjamin J Kurth; Gregory L Osterhaus; Michael A Johnson
Journal:  J Neurochem       Date:  2009-11-19       Impact factor: 5.372

7.  Suppression of mutant Huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability.

Authors:  Sayuko Kaminosono; Taro Saito; Fumitaka Oyama; Toshio Ohshima; Akiko Asada; Yoshitaka Nagai; Nobuyuki Nukina; Shin-Ichi Hisanaga
Journal:  J Neurosci       Date:  2008-08-27       Impact factor: 6.167

8.  Polyglutamine- and temperature-dependent conformational rigidity in mutant huntingtin revealed by immunoassays and circular dichroism spectroscopy.

Authors:  Valentina Fodale; Natalie C Kegulian; Margherita Verani; Cristina Cariulo; Lucia Azzollini; Lara Petricca; Manuel Daldin; Roberto Boggio; Alessandro Padova; Rainer Kuhn; Robert Pacifici; Douglas Macdonald; Ryan C Schoenfeld; Hyunsun Park; J Mario Isas; Ralf Langen; Andreas Weiss; Andrea Caricasole
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

9.  Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegans.

Authors:  Cindy Voisine; Hemant Varma; Nicola Walker; Emily A Bates; Brent R Stockwell; Anne C Hart
Journal:  PLoS One       Date:  2007-06-06       Impact factor: 3.240

10.  Novel Metabolic Abnormalities in the Tricarboxylic Acid Cycle in Peripheral Cells From Huntington's Disease Patients.

Authors:  Nima N Naseri; Joseph Bonica; Hui Xu; Larry C Park; Jamshid Arjomand; Zhengming Chen; Gary E Gibson
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.